D. Yaeger

(+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist.

J. Eckman, S. Hwang, C. Qian, 1998, Journal of medicinal chemistry.

Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor

J. Eckman, Xiong Cai, C. Qian, 1995 .

A ligand-reversible dimerization system for controlling protein-protein interactions.

D N Woolfson, D. Holt, M. Hatada, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins.

D. Holt, T. Clackson, V. Rivera, 1998, Bioorganic & medicinal chemistry.

A ligand-reversible dimerization system for controlling protein-protein interactions.

M. Hatada, T. Clackson, D. Woolfson, 2000, Proceedings of the National Academy of Sciences of the United States of America.